Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-Cohort Phase IIb Clinical Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors

NCT07321574 is registered in ClinicalTrials.gov with Shanghai AB PharmaTech Ltd. as lead sponsor.

NCT NCT07321574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-Cohort Phase IIb Clinical Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
Lead sponsor
Shanghai AB PharmaTech Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
December 30, 2025
Completion date
December 31, 2028
Enrollment
110 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, sclc, extensive stage